by palligoelme@gmail.com | Dec 12, 2025 | Clinical Trials
Conditions: High Risk Neuroblastoma Interventions: Drug: Oral administration of eflornithine for the prevention of high-risk neuroblastoma Sponsors: Shanghai Children’s Hospital; Ruijin Hospital Active, not recruiting Conditions: High Risk Neuroblastoma...
by palligoelme@gmail.com | Dec 12, 2025 | Clinical Trials
Conditions: Motor Learning and Physiological Adaptation Interventions: Other: Training with an exoskeleton Sponsors: Centre National d’Etudes Spatiales; MEDES Institut de Médecine et de Physiologie Spatiales, Toulouse Active, not recruiting Conditions: Motor...
by palligoelme@gmail.com | Dec 12, 2025 | Clinical Trials
Conditions: Immune Checkpoint Inhibitors Related Myocarditis Interventions: Other: rehabilitation protocol Sponsors: China-Japan Friendship Hospital; Weifang Hospital of Traditional Chinese Medicine; Chinese Academy of Medical Sciences, Fuwai Hospital; Second...
by palligoelme@gmail.com | Dec 11, 2025 | Clinical Trials
Conditions: Autism Spectrum Disorder Interventions: Device: Functional Neurogenesis Stimulation Therapy; Other: placebo control group Sponsors: Neurocytonix, Inc. Not yet recruiting Conditions: Autism Spectrum Disorder Interventions: Device: Functional Neurogenesis...
by palligoelme@gmail.com | Dec 11, 2025 | Clinical Trials
Conditions: Postoperative Delirium; Sedation; Remimazolam; Hip Arthroplasty, Total Interventions: Drug: remimazolam sedation reversal with flumazenil; Drug: placebo Sponsors: Medical University of Gdansk Not yet recruiting Conditions: Postoperative Delirium;...
by palligoelme@gmail.com | Dec 11, 2025 | Clinical Trials
Conditions: NK T-Cell Lymphoma Interventions: Drug: Thiotepa Sponsors: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting Conditions: NK T-Cell Lymphoma Interventions: Drug: Thiotepa Sponsors: Shanghai General Hospital,...
